fda glp-1 compounding crackdown october 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA GLP-1 Compounding Crackdown
Description
Storage conditions are summarized in the following table: Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for Use)

The goal is to support overall health, preserve muscle mass, reduce side effects, and ensure youre getting adequate nutrition
This lets participants use pre-tax dollars for these costly medications without disrupting how they manage benefits

GLP-1RA intervention was not associated with fatigue when compared to those given metformin or placebo (OR = 0.18

Pancreatic considerations Pancreatitis is a rare but serious risk associated with all incretin-based therapies
